Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of AGAMREE® (vamorolone) ...

Sidra Medicine, a member of Qatar Foundation, has made significant strides in improving patient care and healthcare access in ...

(SIX: SANN) announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of AGAMREE® (vamorolone) in countries where the product is not otherwise ...

Delpacibart zotadirsen is under clinical development by Avidity Biosciences and currently in Phase II for Duchenne Muscular Dystrophy.

The Percheron Therapeutics (ASX:PER) board of directors has written a letter to shareholders following failure of its phase ...

Capricor Therapeutics seeks US FDA approval for deramiocel for the treatment of Duchenne muscular dystrophy: San Diego Saturday, January 4, 2025, 15:00 Hrs [IST] Capricor Therapeu ...

Here are the top medical news for the dayUnderstanding Duchenne Muscular Dystrophy: Study Unveils Critical Protein ...

A new study has shed light on the complex interactions between dystrophin, a protein critical to muscle stability, and its ...

Maxim Group analyst Jason McCarthy maintained a Buy rating on Capricor Therapeutics (CAPR – Research Report) yesterday and set a price target ...

Una Ennis has taken to social media to describe how she and her husband Keith were told their eldest child has Duchenne ...

Deramiocel is a cell therapy that has healing effects in muscle cells. If approved, deramiocel would be a once-quarterly ...

Shares of Capricor Therapeutics CAPR gained 8.4% on Thursday following the completion of the submission of a biologics ...